After promising on multiple occasions that Oxford vaccine will be provided on a not-for-profit basis for the duration of the pandemic across the world, and in perpetuity to low- and middle-income countries, AstraZeneca came up with riders while signing an agreement with Brazil. And Serum Institute has been brazenly violating the spirit of the agreement … Continue reading Reneging on the ‘no-profit pledge’ to supply Oxford vaccine
Bangladesh
Bangladesh: women’s education cuts maternal, child mortality
Bangladesh is a classic case of how a low- and middle-income country can achieve something which others have failed to. It reduced its maternal mortality by 66 per cent between 1990 and 2010; the reduction was 40 per cent between 2001 and 2010 alone. These were achieved by lowering the maternal mortality rate (the number … Continue reading Bangladesh: women’s education cuts maternal, child mortality
Editorial: More than baby steps required
One more health-status indicator has recently been published, and as expected, India brings up the rear. Despite reducing under-five mortality from 2.5 million in 2001 to 1.4 million in 2012, India still holds the dubious distinction of having the highest number of deaths in the world in this vulnerable age group — 22 per cent. … Continue reading Editorial: More than baby steps required
Indian cholera vaccine found to be safe, efficacious
Published in The Hindu on August 2, 2015 The safety and efficacy of oral cholera vaccine Shanchol manufactured by the Hyderabad-based Shantha Biotechnics Private Limited, a Sanofi company, have been proved in a large-scale field trial involving 94,675 people in Dhaka, Bangladesh. The efficacy of the vaccine delivered through routine government services to poor urban … Continue reading Indian cholera vaccine found to be safe, efficacious
Science Chronicle 